ストックスクリーナーアプリを入手
1.55
0.64%
-0.01
アフターアワーズ：
1.58
0.03
+1.94%
前日終値:
$1.56
開ける：
$1.6
24時間の取引高:
49,188
Relative Volume:
0.05
時価総額：
$6.24M
収益：
-
当期純損益:
$-8.22M
株価収益率:
-0.0567
EPS:
-27.3467
ネットキャッシュフロー:
$-8.01M
1週間 パフォーマンス:
-1.27%
1か月 パフォーマンス:
+6.90%
6か月 パフォーマンス:
-34.60%
1年 パフォーマンス:
-88.36%
1日の値動き範囲:
$1.53
$1.63
1週間の範囲:
$1.43
$1.75
52週間の値動き範囲:
$1.25
$17.64
Enveric Biosciences Inc Stock (ENVB) Company Profile
名前
Enveric Biosciences Inc
セクター
電話
(617) 444-8400
住所
245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE
Compare ENVB vs VRTX, REGN, ARGX, RVMD, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ENVB
Enveric Biosciences Inc
|
1.55 | 5.40M | 0 | -8.22M | -8.01M | -27.35 |
VRTX
Vertex Pharmaceuticals Inc
|
496.07 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
784.36 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
865.04 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
205.15 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
348.27 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Enveric Biosciences Inc (ENVB) 最新ニュース
Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development - Investing News Network
Enveric Biosciences Inc (ENVB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ENVB|Enveric Biosciences Inc|Price:1.137|Chg%:-0.203 - TradingKey
TradingKey - TradingKey
ENVB|Enveric Biosciences Inc|Price:1.290|Chg%:-0.030 - TradingKey
Enveric Biosciences Inc (ENVB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enveric Biosciences Inc (ENVB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
FDA Fast-Tracks Psychedelic Research After Trump’s Executive Order — CMPS, HELP Stocks Gain - Stocktwits
Enveric Biosciences Inc (ENVB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
ENVB Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
Stock market today: Perfect Moment posted rise of 89.86% whereas Enveric Biosciences saw fall of 45.64% in early trading - Business Upturn
Enveric Biosciences Inc (ENVB:UW): Stock Price, Quote and News - BNN Bloomberg
Price to sales forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView
Price to sales forward of Enveric Biosciences, Inc. – BOATS:ENVB - TradingView
MSN Money - MSN
Enterprise value to EBITDA forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView
Price to book forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView
Enveric Biosciences (ENVB) Slips 5.6%: Testing Key Support as Biotech Sentiment WanesRevenue Weighted - dars.gov.et
Enveric Biosciences (ENVB) Rebounds Slightly, Testing Key Resistance Near $1.50Earnings Miss Risk - dars.gov.et
Enterprise value to EBIT forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView
Price to earnings forward of Enveric Biosciences, Inc. – NASDAQ:ENVB - TradingView
ENVB Q4 2024 Earnings: Significant EPS Miss Highlights Ongoing R&D Investment Amid Pre-Revenue StageEarnings Quality Score - dars.gov.et
Enveric Biosciences to Participate in B. Riley's Mind, Muscle & Vision Summit - GuruFocus
Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit - Business Wire
Enveric Biosciences Announces Withdrawal Of Petition Against Its Patent — ENVB Stock Rises - Stocktwits
ENVBEnveric Biosciences Inc Earnings - Finviz
Enveric Biosciences Company Profile & Introduction - Moomoo
Enveric Biosciences, Inc. Actuals & Estimates (NASDAQ:ENVB) - TradingView
Enveric Biosciences Inc (ENVB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Enveric Biosciences Inc (ENVB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ENVERIC BIOSCIENCES INC (ENVB) Stock Chart - ChartMill
Enveric Biosciences Inc (ENVB) Institutional Confidence - TradingKey
Enveric Biosciences Inc (ENVB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Enveric Biosciences Inc (ENVB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Enveric Biosciences Announces Participation in 2026 BIO International Convention - Investing News Network
Enveric Biosciences Inc Annual Shareholders Meeting Transcript - GuruFocus
ENVB Q4 2024 Earnings: Deep EPS Miss Reflects Clinical-Stage ChallengesQuarterly Financial Update - dars.gov.et
ENVB SEC FilingsEnveric Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Enveric Biosciences Expands At-The-Market Equity Offering - TipRanks
Enveric Biosciences (NASDAQ: ENVB) expands $2.4M at-the-market stock program - Stock Titan
Enveric Biosciences (ENVB) amends ATM; $2.425M remaining capacity - Stock Titan
Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day - Investing News Network
Enveric Biosciences Releases Updated Investor Presentation Materials - TipRanks
Enveric Biosciences posts investor presentation on website under Regulation FD - TradingView
Enveric Biosciences (NASDAQ: ENVB) furnishes Q2 2026 investor presentation - Stock Titan
Enveric Biosciences (ENVB) Slides 8%: Support Test Looms as Biotech Sentiment WanesPercent Below MA - dars.gov.et
ENVB News | ENVERIC BIOSCIENCES INC (NASDAQ:ENVB) - ChartMill
[Form 4] Enveric Biosciences, Inc. Insider Trading Activity - Stock Titan
Enveric Biosciences (ENVB) CFO awarded 133,333 RSUs in long-term equity grant - Stock Titan
Enveric Biosciences (ENVB) CEO granted 201,124 RSUs under 2020 long-term plan - Stock Titan
Enveric Biosciences (ENVB) director receives 18,518 restricted stock shares as equity grant - Stock Titan
Enveric Biosciences Inc (ENVB) 財務データ
収益
当期純利益
現金流量
EPS
1.84%
0.86%
大文字化:
|
ボリューム (24 時間):